Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Antidilutive Securities (Details)

v3.21.1
Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 5,050,505 8,380,661
Options to purchase common stock    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 785,399
Unvested RSUs and PSUs    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 2,074,757
Warrants    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 470,000
Convertible Notes due 2023    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 5,050,505 5,050,505